Latest Biotech News

The US Food and Drug Administration has raised safety concerns regarding GSK's antibody-drug conjugate Blenrep (belantamab mafodotin) for multiple myeloma patients, focusing on ocular toxicities...

Merck & Co. has acquired Verona Pharma for $10 billion, securing rights to Ohtuvayre, a novel respiratory drug approved in 2024 for chronic obstructive pulmonary disorder (COPD). The drug relaxes...

The Global Neurodegeneration Proteomics Consortium (GNPC) published findings from one of the largest proteomic datasets, comprising approximately 250 million unique protein measurements from over...

Researchers and industry leaders are advancing biomanufacturing through agentic AI and digital twin technologies to overcome current limitations. Systems like SIC (sense, infer, and control)...

The FDA faces significant staffing challenges with over 380 departures at the Center for Drug Evaluation and Research between January and June 2025, alongside minimal new hires. This attrition...

International scientists developed an affordable, lyophilized reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for pathogen detection aimed at resource-limited...

China-based Sino Biopharmaceutical has completed the acquisition of the remaining 95.09% stake in LaNova Medicines, valuing the deal at approximately $951 million, including the cash and deposits...

Recent studies have advanced understanding of gene regulation and systemic signaling in plants, including a mobile transcription factor coordinating nitrogen deficiency responses across plant...

A new study published in Radiocarbon reveals that micro-computerized tomography (micro-CT), a widely used technique believed to be non-destructive, may actually impact the preservation of fossils....

At the Bioprocess Engineering 2025 meeting in Bremen, researchers from Zurich University of Applied Sciences and Levitronix presented a novel benchtop bioreactor that uses magnetic levitation for...

Researchers highlight the manufacturing challenges that impede cell therapies for heart attack and propose 'cell-free' approaches using proteins and secretomes as easier-to-make alternatives....

A team led by Dr. Moo Sun Hong at Seoul National University is optimizing digital twin models for end-to-end biomanufacturing by leveraging eight years of data sets collected originally at MIT....

Researchers from the Technical University of Denmark and industry partners, including Novo Nordisk and SiC Systems, have developed an integrated agentic AI platform called SIC that autonomously...

Johnson & Johnson reported $15.2 billion in Q2 pharmaceutical sales, surpassing $15 billion for the first time despite a 43% decline in Stelara revenue due to biosimilar competition. Growth in...

Vinay Prasad, head of the FDA’s vaccine regulation office, overruled agency reviewers to narrowly approve Moderna’s Spikevax COVID-19 vaccine only for children aged 6 months to 11 years at...

Swiss-German radiopharmaceutical firm Nuclidium raised $98 million in a Series B round led by Kurma Growth Opportunities Fund and other investors. The funding supports clinical development and...

Ahead of the FDA Oncologic Drugs Advisory Committee meeting, regulators released briefing documents raising concerns over GSK’s antibody-drug conjugate Blenrep's ocular toxicity and uncertain safe...

Merck & Co. finalized its $10 billion acquisition of Verona Pharma, gaining the respiratory drug Ohtuvayre approved in 2024 for chronic obstructive pulmonary disease. Despite the original...

Kenvue, the consumer health spinout from Johnson & Johnson, has initiated a CEO transition with Thibaut Mongon stepping down and board member Kirk Perry appointed interim CEO. This leadership...

The Perigenomed initiative in France is pioneering routine genome sequencing-based newborn screening to detect hundreds of treatable rare diseases before symptoms emerge. CHU Dijon has sequenced...